The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014
COPD subtypes at greatest risk of pneumonia: Cluster analysis Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014
Defining asthma COPD overlap syndrome (ACOS): A population based study Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016
Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
COPD prevalence in Argentina: The EPOC.AR study Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016
Symptoms of COPD in the general population are associated with overweight and obesity Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016
Detection of previously undiagnosed COPD: A role for bronchodilator reversibility testing? Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013
Prevalence and characteristics of the asthma-COPD overlap syndrome - or the asthma-like COPD phenotype - in a COPD high risk population Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Role of tuberculosis in COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
SP-D as a biomarker for COPD in the Lebanese population Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013